nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—allergic rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.454	1	CpDpCtD
Ephedrine—ADRB2—chronic obstructive pulmonary disease	0.237	1	CbGaD
Ephedrine—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0942	0.397	CbGbCtD
Ephedrine—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0714	0.301	CbGbCtD
Ephedrine—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0714	0.301	CbGbCtD
Ephedrine—Prostatic hypertrophy—Tiotropium—chronic obstructive pulmonary disease	0.00745	0.127	CcSEcCtD
Ephedrine—Benign prostatic hyperplasia—Tiotropium—chronic obstructive pulmonary disease	0.00405	0.0688	CcSEcCtD
Ephedrine—Epigastric distress—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.0235	CcSEcCtD
Ephedrine—Extrasystoles—Aminophylline—chronic obstructive pulmonary disease	0.000885	0.015	CcSEcCtD
Ephedrine—BCHE—diaphragm—chronic obstructive pulmonary disease	0.000792	0.563	CbGeAlD
Ephedrine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—chronic obstructive pulmonary disease	0.000771	0.0799	CbGpPWpGaD
Ephedrine—Extrasystoles—Formoterol—chronic obstructive pulmonary disease	0.000674	0.0115	CcSEcCtD
Ephedrine—Extrasystoles—Arformoterol—chronic obstructive pulmonary disease	0.000674	0.0115	CcSEcCtD
Ephedrine—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.000666	0.0113	CcSEcCtD
Ephedrine—Pallor—Salbutamol—chronic obstructive pulmonary disease	0.000646	0.011	CcSEcCtD
Ephedrine—Extrasystoles—Salbutamol—chronic obstructive pulmonary disease	0.000636	0.0108	CcSEcCtD
Ephedrine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—chronic obstructive pulmonary disease	0.000628	0.0652	CbGpPWpGaD
Ephedrine—Blood pressure increased—Arformoterol—chronic obstructive pulmonary disease	0.000567	0.00964	CcSEcCtD
Ephedrine—Blood pressure increased—Formoterol—chronic obstructive pulmonary disease	0.000567	0.00964	CcSEcCtD
Ephedrine—Blood pressure increased—Salbutamol—chronic obstructive pulmonary disease	0.000535	0.0091	CcSEcCtD
Ephedrine—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.000516	0.00877	CcSEcCtD
Ephedrine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.000514	0.00874	CcSEcCtD
Ephedrine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.000485	0.00824	CcSEcCtD
Ephedrine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.000479	0.00815	CcSEcCtD
Ephedrine—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00814	CcSEcCtD
Ephedrine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.000474	0.00806	CcSEcCtD
Ephedrine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.000469	0.00798	CcSEcCtD
Ephedrine—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00046	0.00782	CcSEcCtD
Ephedrine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000457	0.00778	CcSEcCtD
Ephedrine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000439	0.00746	CcSEcCtD
Ephedrine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000431	0.00734	CcSEcCtD
Ephedrine—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.000429	0.0073	CcSEcCtD
Ephedrine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.000414	0.00704	CcSEcCtD
Ephedrine—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.000412	0.00701	CcSEcCtD
Ephedrine—Irritability—Montelukast—chronic obstructive pulmonary disease	0.000385	0.00654	CcSEcCtD
Ephedrine—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.0063	CcSEcCtD
Ephedrine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00036	0.00613	CcSEcCtD
Ephedrine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000351	0.00596	CcSEcCtD
Ephedrine—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.000346	0.00589	CcSEcCtD
Ephedrine—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.000346	0.00589	CcSEcCtD
Ephedrine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000346	0.00589	CcSEcCtD
Ephedrine—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000334	0.00568	CcSEcCtD
Ephedrine—ADRA1A—Adrenoceptors—ADRB2—chronic obstructive pulmonary disease	0.000333	0.0345	CbGpPWpGaD
Ephedrine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000328	0.00558	CcSEcCtD
Ephedrine—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00556	CcSEcCtD
Ephedrine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00032	0.00543	CcSEcCtD
Ephedrine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000316	0.00538	CcSEcCtD
Ephedrine—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000315	0.00536	CcSEcCtD
Ephedrine—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00534	CcSEcCtD
Ephedrine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000305	0.00519	CcSEcCtD
Ephedrine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000299	0.00509	CcSEcCtD
Ephedrine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000288	0.00489	CcSEcCtD
Ephedrine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00488	CcSEcCtD
Ephedrine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000286	0.00486	CcSEcCtD
Ephedrine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00472	CcSEcCtD
Ephedrine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000276	0.0047	CcSEcCtD
Ephedrine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000271	0.00461	CcSEcCtD
Ephedrine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000265	0.00451	CcSEcCtD
Ephedrine—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.00448	CcSEcCtD
Ephedrine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000264	0.00448	CcSEcCtD
Ephedrine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.00444	CcSEcCtD
Ephedrine—Delirium—Prednisone—chronic obstructive pulmonary disease	0.000259	0.00441	CcSEcCtD
Ephedrine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000259	0.00441	CcSEcCtD
Ephedrine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00432	CcSEcCtD
Ephedrine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00432	CcSEcCtD
Ephedrine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000253	0.00431	CcSEcCtD
Ephedrine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000253	0.00431	CcSEcCtD
Ephedrine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000251	0.00427	CcSEcCtD
Ephedrine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000251	0.00427	CcSEcCtD
Ephedrine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00025	0.00424	CcSEcCtD
Ephedrine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.00416	CcSEcCtD
Ephedrine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00413	CcSEcCtD
Ephedrine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00413	CcSEcCtD
Ephedrine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00409	CcSEcCtD
Ephedrine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00409	CcSEcCtD
Ephedrine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00024	0.00409	CcSEcCtD
Ephedrine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00408	CcSEcCtD
Ephedrine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00405	CcSEcCtD
Ephedrine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00405	CcSEcCtD
Ephedrine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000237	0.00402	CcSEcCtD
Ephedrine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000234	0.00398	CcSEcCtD
Ephedrine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00397	CcSEcCtD
Ephedrine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00395	CcSEcCtD
Ephedrine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00395	CcSEcCtD
Ephedrine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000231	0.00393	CcSEcCtD
Ephedrine—SLC18A2—Synaptic Vesicle Pathway—SLC6A4—chronic obstructive pulmonary disease	0.00023	0.0238	CbGpPWpGaD
Ephedrine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.0039	CcSEcCtD
Ephedrine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00387	CcSEcCtD
Ephedrine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00387	CcSEcCtD
Ephedrine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000227	0.00387	CcSEcCtD
Ephedrine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00386	CcSEcCtD
Ephedrine—ACHE—Monoamine Transport—SLC6A4—chronic obstructive pulmonary disease	0.000227	0.0235	CbGpPWpGaD
Ephedrine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000227	0.00385	CcSEcCtD
Ephedrine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00382	CcSEcCtD
Ephedrine—SLC6A2—Monoamine Transport—SLC6A4—chronic obstructive pulmonary disease	0.000224	0.0233	CbGpPWpGaD
Ephedrine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00379	CcSEcCtD
Ephedrine—ACHE—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000222	0.023	CbGpPWpGaD
Ephedrine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000221	0.00375	CcSEcCtD
Ephedrine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00373	CcSEcCtD
Ephedrine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00372	CcSEcCtD
Ephedrine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00372	CcSEcCtD
Ephedrine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00366	CcSEcCtD
Ephedrine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—chronic obstructive pulmonary disease	0.000215	0.0223	CbGpPWpGaD
Ephedrine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00365	CcSEcCtD
Ephedrine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00364	CcSEcCtD
Ephedrine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00364	CcSEcCtD
Ephedrine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00359	CcSEcCtD
Ephedrine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00359	CcSEcCtD
Ephedrine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00357	CcSEcCtD
Ephedrine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00357	CcSEcCtD
Ephedrine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00357	CcSEcCtD
Ephedrine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00021	0.00357	CcSEcCtD
Ephedrine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00352	CcSEcCtD
Ephedrine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000206	0.0035	CcSEcCtD
Ephedrine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00343	CcSEcCtD
Ephedrine—Phenylpropanolamine—ADRB2—chronic obstructive pulmonary disease	0.000201	0.0974	CrCbGaD
Ephedrine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00339	CcSEcCtD
Ephedrine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00337	CcSEcCtD
Ephedrine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00336	CcSEcCtD
Ephedrine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00336	CcSEcCtD
Ephedrine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00326	CcSEcCtD
Ephedrine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—chronic obstructive pulmonary disease	0.000192	0.0199	CbGpPWpGaD
Ephedrine—Pseudoephedrine—TNF—chronic obstructive pulmonary disease	0.000191	0.0928	CrCbGaD
Ephedrine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00317	CcSEcCtD
Ephedrine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00314	CcSEcCtD
Ephedrine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00311	CcSEcCtD
Ephedrine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00311	CcSEcCtD
Ephedrine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00309	CcSEcCtD
Ephedrine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00018	0.00307	CcSEcCtD
Ephedrine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.00307	CcSEcCtD
Ephedrine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00305	CcSEcCtD
Ephedrine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.00303	CcSEcCtD
Ephedrine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000178	0.00303	CcSEcCtD
Ephedrine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000176	0.00299	CcSEcCtD
Ephedrine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000174	0.00296	CcSEcCtD
Ephedrine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00294	CcSEcCtD
Ephedrine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00294	CcSEcCtD
Ephedrine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00294	CcSEcCtD
Ephedrine—ACHE—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000172	0.0179	CbGpPWpGaD
Ephedrine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00289	CcSEcCtD
Ephedrine—Pseudoephedrine—ADRB2—chronic obstructive pulmonary disease	0.00017	0.0823	CrCbGaD
Ephedrine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00288	CcSEcCtD
Ephedrine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000169	0.00287	CcSEcCtD
Ephedrine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00286	CcSEcCtD
Ephedrine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000168	0.00285	CcSEcCtD
Ephedrine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000167	0.00285	CcSEcCtD
Ephedrine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00283	CcSEcCtD
Ephedrine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00283	CcSEcCtD
Ephedrine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000166	0.00283	CcSEcCtD
Ephedrine—Phenylpropanolamine—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.0805	CrCbGaD
Ephedrine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00282	CcSEcCtD
Ephedrine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000166	0.00282	CcSEcCtD
Ephedrine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00278	CcSEcCtD
Ephedrine—Phentermine—SLC6A4—chronic obstructive pulmonary disease	0.000163	0.0788	CrCbGaD
Ephedrine—ACHE—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000161	0.0167	CbGpPWpGaD
Ephedrine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00016	0.00272	CcSEcCtD
Ephedrine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.00272	CcSEcCtD
Ephedrine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000159	0.00271	CcSEcCtD
Ephedrine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00269	CcSEcCtD
Ephedrine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000158	0.00269	CcSEcCtD
Ephedrine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000158	0.00268	CcSEcCtD
Ephedrine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000158	0.00268	CcSEcCtD
Ephedrine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00268	CcSEcCtD
Ephedrine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000157	0.00267	CcSEcCtD
Ephedrine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00267	CcSEcCtD
Ephedrine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00266	CcSEcCtD
Ephedrine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00263	CcSEcCtD
Ephedrine—Pseudoephedrine—SLC6A4—chronic obstructive pulmonary disease	0.000154	0.0747	CrCbGaD
Ephedrine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00257	CcSEcCtD
Ephedrine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000149	0.00253	CcSEcCtD
Ephedrine—Phentermine—CYP1A2—chronic obstructive pulmonary disease	0.000148	0.0718	CrCbGaD
Ephedrine—Benzyl alcohol—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.0718	CrCbGaD
Ephedrine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.00247	CcSEcCtD
Ephedrine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000145	0.00247	CcSEcCtD
Ephedrine—Benzyl alcohol—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.0692	CrCbGaD
Ephedrine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00242	CcSEcCtD
Ephedrine—ACHE—ATF-2 transcription factor network—TGFB2—chronic obstructive pulmonary disease	0.000142	0.0147	CbGpPWpGaD
Ephedrine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.00234	CcSEcCtD
Ephedrine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00233	CcSEcCtD
Ephedrine—Selegiline—CYP1A2—chronic obstructive pulmonary disease	0.000137	0.0664	CrCbGaD
Ephedrine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00227	CcSEcCtD
Ephedrine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00227	CcSEcCtD
Ephedrine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000131	0.00223	CcSEcCtD
Ephedrine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00219	CcSEcCtD
Ephedrine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00219	CcSEcCtD
Ephedrine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00217	CcSEcCtD
Ephedrine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00217	CcSEcCtD
Ephedrine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00217	CcSEcCtD
Ephedrine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00217	CcSEcCtD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000127	0.0132	CbGpPWpGaD
Ephedrine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00215	CcSEcCtD
Ephedrine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00215	CcSEcCtD
Ephedrine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00215	CcSEcCtD
Ephedrine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00214	CcSEcCtD
Ephedrine—Amphetamine—SLC6A4—chronic obstructive pulmonary disease	0.000125	0.0606	CrCbGaD
Ephedrine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00212	CcSEcCtD
Ephedrine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00212	CcSEcCtD
Ephedrine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000124	0.00211	CcSEcCtD
Ephedrine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00206	CcSEcCtD
Ephedrine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.00205	CcSEcCtD
Ephedrine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00205	CcSEcCtD
Ephedrine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00205	CcSEcCtD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00012	0.0125	CbGpPWpGaD
Ephedrine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.00204	CcSEcCtD
Ephedrine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00012	0.00204	CcSEcCtD
Ephedrine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00203	CcSEcCtD
Ephedrine—ADRA1A—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000118	0.0122	CbGpPWpGaD
Ephedrine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000118	0.002	CcSEcCtD
Ephedrine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.00197	CcSEcCtD
Ephedrine—Methamphetamine—SLC6A4—chronic obstructive pulmonary disease	0.000116	0.0561	CrCbGaD
Ephedrine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00194	CcSEcCtD
Ephedrine—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	0.000114	0.0553	CrCbGaD
Ephedrine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00193	CcSEcCtD
Ephedrine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00189	CcSEcCtD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000111	0.0115	CbGpPWpGaD
Ephedrine—ADRB2—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000111	0.0115	CbGpPWpGaD
Ephedrine—SLC6A2—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00011	0.0114	CbGpPWpGaD
Ephedrine—SLC6A2—respiratory system—chronic obstructive pulmonary disease	0.000109	0.0778	CbGeAlD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000107	0.0111	CbGpPWpGaD
Ephedrine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.00182	CcSEcCtD
Ephedrine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.0018	CcSEcCtD
Ephedrine—ADRA1A—Endothelin Pathways—EDN1—chronic obstructive pulmonary disease	0.000105	0.0109	CbGpPWpGaD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000104	0.0107	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.000101	0.0104	CbGpPWpGaD
Ephedrine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.0001	0.0017	CcSEcCtD
Ephedrine—SLC18A2—Dopaminergic Neurogenesis—TGFB1—chronic obstructive pulmonary disease	9.92e-05	0.0103	CbGpPWpGaD
Ephedrine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.91e-05	0.00168	CcSEcCtD
Ephedrine—ADRA1A—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	9.9e-05	0.0103	CbGpPWpGaD
Ephedrine—ADRB2—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	9.76e-05	0.0101	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	9.73e-05	0.0101	CbGpPWpGaD
Ephedrine—ACHE—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	9.54e-05	0.00989	CbGpPWpGaD
Ephedrine—SLC18A2—lung—chronic obstructive pulmonary disease	9.52e-05	0.0677	CbGeAlD
Ephedrine—Pain—Prednisolone—chronic obstructive pulmonary disease	9.37e-05	0.00159	CcSEcCtD
Ephedrine—ADRB2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	9.35e-05	0.0097	CbGpPWpGaD
Ephedrine—ADRA1A—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	9.2e-05	0.00954	CbGpPWpGaD
Ephedrine—BCHE—respiratory system—chronic obstructive pulmonary disease	9.04e-05	0.0643	CbGeAlD
Ephedrine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	9.03e-05	0.00153	CcSEcCtD
Ephedrine—Agitation—Prednisone—chronic obstructive pulmonary disease	8.96e-05	0.00152	CcSEcCtD
Ephedrine—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.76e-05	0.00149	CcSEcCtD
Ephedrine—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	8.76e-05	0.0425	CrCbGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	8.65e-05	0.00897	CbGpPWpGaD
Ephedrine—BCHE—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	8.51e-05	0.00882	CbGpPWpGaD
Ephedrine—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.42e-05	0.00143	CcSEcCtD
Ephedrine—Anxiety—Prednisone—chronic obstructive pulmonary disease	8.27e-05	0.00141	CcSEcCtD
Ephedrine—ACHE—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	8.25e-05	0.00856	CbGpPWpGaD
Ephedrine—SLC6A2—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	8.16e-05	0.00846	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	8.09e-05	0.00839	CbGpPWpGaD
Ephedrine—ACHE—ATF-2 transcription factor network—PLAU—chronic obstructive pulmonary disease	8.05e-05	0.00835	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	7.94e-05	0.00823	CbGpPWpGaD
Ephedrine—SLC6A2—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	7.84e-05	0.00812	CbGpPWpGaD
Ephedrine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.77e-05	0.00132	CcSEcCtD
Ephedrine—ADRA1A—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	7.74e-05	0.00802	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	7.72e-05	0.008	CbGpPWpGaD
Ephedrine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.69e-05	0.00131	CcSEcCtD
Ephedrine—ADRA1A—AMPK Signaling—ADIPOQ—chronic obstructive pulmonary disease	7.64e-05	0.00792	CbGpPWpGaD
Ephedrine—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.00129	CcSEcCtD
Ephedrine—BCHE—bronchus—chronic obstructive pulmonary disease	7.44e-05	0.0529	CbGeAlD
Ephedrine—ACHE—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	7.39e-05	0.00767	CbGpPWpGaD
Ephedrine—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	7.28e-05	0.0517	CbGeAlD
Ephedrine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.24e-05	0.00123	CcSEcCtD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	7.21e-05	0.00748	CbGpPWpGaD
Ephedrine—Insomnia—Prednisone—chronic obstructive pulmonary disease	7.2e-05	0.00122	CcSEcCtD
Ephedrine—SLC6A2—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	7.17e-05	0.00743	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	7.05e-05	0.00731	CbGpPWpGaD
Ephedrine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	7.01e-05	0.00119	CcSEcCtD
Ephedrine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.92e-05	0.00118	CcSEcCtD
Ephedrine—Rash—Prednisolone—chronic obstructive pulmonary disease	6.91e-05	0.00117	CcSEcCtD
Ephedrine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.9e-05	0.00117	CcSEcCtD
Ephedrine—Headache—Prednisolone—chronic obstructive pulmonary disease	6.86e-05	0.00117	CcSEcCtD
Ephedrine—SLC6A2—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	6.79e-05	0.00704	CbGpPWpGaD
Ephedrine—BCHE—trachea—chronic obstructive pulmonary disease	6.68e-05	0.0475	CbGeAlD
Ephedrine—SLC6A2—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	6.66e-05	0.00691	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	6.63e-05	0.00687	CbGpPWpGaD
Ephedrine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.56e-05	0.00112	CcSEcCtD
Ephedrine—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.51e-05	0.00111	CcSEcCtD
Ephedrine—ADRA1A—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	6.41e-05	0.00665	CbGpPWpGaD
Ephedrine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.00107	CcSEcCtD
Ephedrine—BCHE—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	6.29e-05	0.00652	CbGpPWpGaD
Ephedrine—ACHE—Monoamine Transport—TNF—chronic obstructive pulmonary disease	5.99e-05	0.00621	CbGpPWpGaD
Ephedrine—ACHE—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	5.93e-05	0.00614	CbGpPWpGaD
Ephedrine—SLC6A2—Monoamine Transport—TNF—chronic obstructive pulmonary disease	5.92e-05	0.00614	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	5.91e-05	0.00613	CbGpPWpGaD
Ephedrine—SLC6A2—lung—chronic obstructive pulmonary disease	5.81e-05	0.0413	CbGeAlD
Ephedrine—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.71e-05	0.000971	CcSEcCtD
Ephedrine—ACHE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	5.4e-05	0.0056	CbGpPWpGaD
Ephedrine—BCHE—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	5.29e-05	0.00548	CbGpPWpGaD
Ephedrine—ACHE—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	5.27e-05	0.00547	CbGpPWpGaD
Ephedrine—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.26e-05	0.000895	CcSEcCtD
Ephedrine—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.06e-05	0.00086	CcSEcCtD
Ephedrine—SLC6A2—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	5.03e-05	0.00521	CbGpPWpGaD
Ephedrine—Rash—Prednisone—chronic obstructive pulmonary disease	5.02e-05	0.000853	CcSEcCtD
Ephedrine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.000852	CcSEcCtD
Ephedrine—Headache—Prednisone—chronic obstructive pulmonary disease	4.99e-05	0.000848	CcSEcCtD
Ephedrine—SLC6A2—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	4.96e-05	0.00514	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	4.94e-05	0.00512	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	4.82e-05	0.005	CbGpPWpGaD
Ephedrine—BCHE—lung—chronic obstructive pulmonary disease	4.8e-05	0.0341	CbGeAlD
Ephedrine—ADRB2—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	4.79e-05	0.00497	CbGpPWpGaD
Ephedrine—ADRA1A—AMPK Signaling—LEP—chronic obstructive pulmonary disease	4.74e-05	0.00492	CbGpPWpGaD
Ephedrine—Nausea—Prednisone—chronic obstructive pulmonary disease	4.73e-05	0.000804	CcSEcCtD
Ephedrine—SLC6A2—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	4.62e-05	0.00479	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	4.6e-05	0.00476	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.52e-05	0.00469	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	4.38e-05	0.00454	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	4.1e-05	0.00425	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.03e-05	0.00418	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	3.91e-05	0.00405	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	3.75e-05	0.00389	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	3.62e-05	0.00376	CbGpPWpGaD
Ephedrine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	3.53e-05	0.00365	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	3.49e-05	0.00361	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APIP—chronic obstructive pulmonary disease	3.13e-05	0.00324	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	3.1e-05	0.00322	CbGpPWpGaD
Ephedrine—ACHE—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	2.96e-05	0.00307	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	2.86e-05	0.00296	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APIP—chronic obstructive pulmonary disease	2.79e-05	0.00289	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.79e-05	0.00289	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	2.63e-05	0.00272	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	2.36e-05	0.00245	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.36e-05	0.00245	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	2.35e-05	0.00244	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.34e-05	0.00243	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	2.3e-05	0.00238	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	2.27e-05	0.00236	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.23e-05	0.00231	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.15e-05	0.00223	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.1e-05	0.00218	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.07e-05	0.00215	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	2.06e-05	0.00213	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.05e-05	0.00213	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GC—chronic obstructive pulmonary disease	2.01e-05	0.00209	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2e-05	0.00208	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.99e-05	0.00206	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	1.95e-05	0.00202	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.94e-05	0.00201	CbGpPWpGaD
Ephedrine—ADRA1A—AMPK Signaling—TP53—chronic obstructive pulmonary disease	1.93e-05	0.00201	CbGpPWpGaD
Ephedrine—SLC6A2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	1.88e-05	0.00195	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	1.88e-05	0.00194	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.87e-05	0.00194	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.85e-05	0.00191	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.84e-05	0.00191	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.83e-05	0.0019	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.82e-05	0.00189	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	1.8e-05	0.00187	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GC—chronic obstructive pulmonary disease	1.8e-05	0.00186	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.78e-05	0.00184	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.74e-05	0.0018	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.67e-05	0.00173	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.67e-05	0.00173	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.66e-05	0.00172	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	1.62e-05	0.00168	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.61e-05	0.00167	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	1.61e-05	0.00167	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.6e-05	0.00166	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.59e-05	0.00165	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.54e-05	0.00159	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.52e-05	0.00158	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.51e-05	0.00156	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.5e-05	0.00156	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.49e-05	0.00155	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.48e-05	0.00154	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.47e-05	0.00152	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	1.44e-05	0.0015	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.43e-05	0.00149	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.42e-05	0.00147	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.42e-05	0.00147	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.4e-05	0.00145	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.34e-05	0.00138	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.33e-05	0.00138	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.32e-05	0.00137	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.26e-05	0.00131	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.21e-05	0.00126	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.17e-05	0.00122	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.16e-05	0.0012	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	1.16e-05	0.0012	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.14e-05	0.00118	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	1.12e-05	0.00116	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.1e-05	0.00114	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GCLC—chronic obstructive pulmonary disease	1.09e-05	0.00113	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.07e-05	0.00111	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	1.03e-05	0.00107	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.01e-05	0.00105	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	9.98e-06	0.00103	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CTGF—chronic obstructive pulmonary disease	9.92e-06	0.00103	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.81e-06	0.00102	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GCLC—chronic obstructive pulmonary disease	9.7e-06	0.00101	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.53e-06	0.000988	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	9.4e-06	0.000975	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	9.28e-06	0.000962	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.14e-06	0.000948	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.05e-06	0.000938	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.05e-06	0.000938	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.89e-06	0.000921	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CTGF—chronic obstructive pulmonary disease	8.85e-06	0.000918	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.66e-06	0.000898	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.66e-06	0.000897	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	8.38e-06	0.000869	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.22e-06	0.000852	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.16e-06	0.000846	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.92e-06	0.000821	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.63e-06	0.000791	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.61e-06	0.000789	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.52e-06	0.00078	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.49e-06	0.000776	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	7.43e-06	0.000771	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.19e-06	0.000745	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.16e-06	0.000743	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.16e-06	0.000742	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	7.13e-06	0.000739	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.01e-06	0.000727	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.8e-06	0.000705	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.8e-06	0.000705	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.71e-06	0.000696	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.64e-06	0.000689	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	6.63e-06	0.000688	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.55e-06	0.000679	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.33e-06	0.000657	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.25e-06	0.000648	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.95e-06	0.000617	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.93e-06	0.000614	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.89e-06	0.00061	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.24e-06	0.000543	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.89e-06	0.000507	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.87e-06	0.000505	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.86e-06	0.000503	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ALB—chronic obstructive pulmonary disease	4.52e-06	0.000468	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.49e-06	0.000466	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.44e-06	0.000461	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.41e-06	0.000458	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—NOS3—chronic obstructive pulmonary disease	4.32e-06	0.000448	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.25e-06	0.00044	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.05e-06	0.000419	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ALB—chronic obstructive pulmonary disease	4.03e-06	0.000418	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.02e-06	0.000416	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.95e-06	0.000409	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NOS3—chronic obstructive pulmonary disease	3.85e-06	0.0004	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.67e-06	0.000381	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.65e-06	0.000378	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.51e-06	0.000364	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.27e-06	0.000339	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.25e-06	0.000337	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.1e-06	0.000321	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.96e-06	0.000307	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.69e-06	0.000278	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.62e-06	0.000272	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.56e-06	0.000266	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.5e-06	0.000259	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.45e-06	0.000254	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.37e-06	0.000246	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.17e-06	0.000225	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.13e-06	0.000221	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.06e-06	0.000214	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.96e-06	0.000204	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.96e-06	0.000203	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.92e-06	0.000199	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.76e-06	0.000183	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.62e-06	0.000168	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.61e-06	0.000167	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.59e-06	0.000164	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.47e-06	0.000153	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.33e-06	0.000138	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.22e-06	0.000126	CbGpPWpGaD
